Sutro Biopharma, Inc.
STRO
$0.81
$0.00470.58%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -75.97M | -72.44M | -48.79M | -48.02M | -58.21M |
| Total Depreciation and Amortization | 1.90M | 1.87M | 1.80M | 1.79M | 1.76M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 15.33M | 14.57M | -10.41M | 7.31M | 8.33M |
| Change in Net Operating Assets | -9.15M | -15.74M | -7.12M | 48.37M | -16.62M |
| Cash from Operations | -67.88M | -71.74M | -64.52M | 9.46M | -64.74M |
| Capital Expenditure | -1.17M | -1.07M | -828.00K | -756.00K | -446.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -15.08M | 88.56M | 148.12M | -79.62M | 64.55M |
| Cash from Investing | -16.26M | 87.49M | 147.29M | -80.38M | 64.11M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | 0.00 | 0.00 | 0.00 | -4.08M |
| Issuance of Common Stock | 246.00K | 0.00 | 1.09M | 96.53M | 1.03M |
| Repurchase of Common Stock | -180.00K | -24.00K | -74.00K | -37.00K | -374.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 66.00K | -24.00K | 1.02M | 96.49M | -3.43M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -84.08M | 15.73M | 83.79M | 25.57M | -4.07M |